BioSpace News Archive

New Zealand based soft-tissue regeneration company Aroa Biosurgery is pleased to announce financial results for H1 FY23.

Two studies comparing injections commonly used to relieve the pain of knee osteoarthritis found that corticosteroid injections were associated with the progression of the disease.

The UAB Cardiogenomics Clinic, led by Dr. Pankaj Arora, is partnering with the industry leader for polygenic risk score (PRS) analysis and reporting, Allelica Inc., to perform a clinical implementation study on PRS application for coronary artery disease.

Zynerba Pharmaceuticals, Inc. today announced the presentation of a poster at the 61st Annual Meeting of the American College of Neuropsychopharmacology, being held December 4-7, 2022 in Phoenix, Ariz.

Catheter Precision, Inc. announces the completion of more than 20 procedures at NYU Langone Hospital utilizing the VIVO System that enables physicians to identify the origin of arrhythmias pre-procedure.

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, and Pediatrix Therapeutics, Inc. (Pediatrix), a pediatrics-focused therapeutic company, today announced that the companies have entered into a license agreement.

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, announced the appointment of Scott Garland to its Board of Directors effective November 29, 2022.

Milestone Pharmaceuticals Inc. today announced that members of the Company’s management team will host a virtual commercial deep-dive event on Tuesday, December 6, 2022 at 1:00 p.m. ET.

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Apollo Endosurgery, Inc. (Nasdaq: APEN) for a cash price of $10 per share, reflecting an enterprise value of approximately $615 million.

Avail today announced that Daniel Hawkins , Chief Executive Officer of Avail, will participate in a fireside chat at the Jefferies Virtual Private MedTech Summit on Tuesday, December 6, 2022 at 10:30 a.m. ET.